Our Strategy is Paying Off
Five marketed products with accelerating revenue
Exciting opportunities for expanded use / new indications in major markets
Maturing commercial capabilities, relationships with specialists
Diverse portfolio of 16 products, all targeting major markets
Seven major products in human development, five on human development track, numerous compounds in research and preclinical stages
Cash-flow positive business with major milestones and royalties by 2003
LSPP: Ligand Specialty Pharmaceutical Products
LCPP: Ligand Corporate Partner Products